Healthcare Innovation January 4, 2022
Effective Jan. 1, 2022, Clinical Treatment Act expands clinical trial access to more than 41.6 million Medicaid beneficiaries
A federal law that went into effect on Jan. 1, 2022, requires all states and territories to cover and reimburse for the routine costs of care for services associated with Medicaid enrollee participation in a qualifying clinical trial.
Medicaid insures nearly one-fifth of the U.S. population, yet it was the only major payer not required by federal law to provide coverage for routine costs of participation in a clinical trial.
Cancer advocacy organizations have stressed that access to clinical trials provide individuals with cancer with their best clinical option, and in addition, increasing diversity in clinical trials participation improves the validity of...
Today's Sponsors
Today's Sponsor